Lauriston S. taylor lecture: Radiation protection and public policy in an uncertain world

Health Physics

Volumn 101, Issue 5, 2011, Pages 499-508

  Land, Charles E ^a  

^a Apt 4F ^*  (Portugal)

Author keywords

cancer; National Council on Radiation Protection and Measurements; radiation protection; radiation risk

Indexed keywords

ARTICLE; ENVIRONMENTAL EXPOSURE; HUMAN; INTERNATIONAL COOPERATION; IONIZING RADIATION; LEGAL ASPECT; METHODOLOGY; POLICY; RADIATION DOSE; RADIATION PROTECTION; RISK ASSESSMENT; RISK MANAGEMENT; STATISTICAL MODEL; UNCERTAINTY; UNITED STATES;

ENVIRONMENTAL EXPOSURE; HUMANS; INTERNATIONAL COOPERATION; MODELS, STATISTICAL; PUBLIC POLICY; RADIATION DOSAGE; RADIATION PROTECTION; RADIATION, IONIZING; RISK ASSESSMENT; RISK MANAGEMENT; UNCERTAINTY; UNITED STATES;

ANIMALIA;

EID: 80054041331     PISSN: 00179078     EISSN: None     Source Type: Journal    
DOI: 10.1097/HP.0b013e318227e822     Document Type: Article

References (43)

1. Armstrong BG. The effect of measurement errors on relative risk regressions. Am J Epidemiology 132:1176-1184; 1990.
2. Beebe GW, Ishida M, Jablon S. Studies of the mortality of A-bomb survivors. I. Plan of study and mortality in the medical subsample (selection 1), 1950-1958. Radiation Research 16:253-280; 1962.
3. Berrington de González A, Mahesh M, Kim KP, Bhargavan M, Lewis R, Mettler F, Land C. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 169:2071-2077; 2009.
4. Carr ZA, Kleinerman RA, Weinstock R, Stovall M, Greim ML, Land CE. Malignant neoplasms after radiation therapy for peptic ulcer. Radiat Res 157:668-677; 2002. (Pubitemid 34569135)
5. Cronkite EP. Editorial: the etiologic role of radiation in the development of leukemia. Blood 18:370-376; 1961.
6. Cullings HM, Fujita S, Funamoto S, Grant EJ, Kerr GD, Preston DL. Dose estimation for atomic bomb survivor studies: its evolution and present status. Radiat Res 166:219-254; 2006. (Pubitemid 44051213)
7. Curado MP, Edwards B, Shin HR, Ferlay J, Heanue M, Boyle P, Storm H. Cancer incidence in five continents. Lyon: IARC; Volume IX, IARC Scientific Publication, No 160; 2009.
8. Folley JH, Borges W, Yamasaki T. Incidence of leukemia in survivors of the atom bomb in Hiroshima and Nagasaki, Japan. Am J Med 13:311-321; 1952.
9. Furukawa K, Preston DL, Lonn S, Funamoto S, Yonehara S, Matsuo T, Egawa H, Tokuoka S, Ozasa K, Kasagi F, Kodama K, Mabuchi K. Radiation and smoking effects on lung cancer incidence among atomic bomb survivors. Ra-diat Res 174:72-82; 2010.
10. Gilbert ES. Some effects of random dose measurement errors on analyses of atomic bomb survivor data. Radiat Res 98:591-605; 1984. (Pubitemid 14123025)
11. Ishimaru T, Hoshino T, Ichimaru M, Okada H, Tomiyasu T. Leukemia in atomic bomb survivors, Hiroshima and Nagasaki, 1 October 1950-30 September 1966. Radiat Res 45:216-233; 1971.
12. International Commission on Radiological Protection. Low-dose extrapolation of radiation-related cancer risk. New York: Elsevier; ICRP Publication 99, Ann ICRP 35, 2006.
13. Jablon S. Atomic bomb radiation dose estimation at ABCC. Hiroshima: Atomic Bomb Casualty Commission TR/23-71; 1971.
14. Kaul DC. The origin of DS86. In: Peterson LE, Abrahamson S, eds. Effects of ionizing radiation. Atomic bomb survivors and their children (1945-1995). Washington, DC: Joseph Henry Press; 1998; 31-50.
15. Kerr GD. Development of A-bomb survivor dosimetry. In: Peterson LE, Abrahamson S, eds. Effects of ionizing radiation. Atomic bomb survivors and their children (1945-1995). Washington, DC: Joseph Henry Press; 1998; 3-30.
16. Kocher D, Apostoaei, Henshaw RW, Hoffman FO, Schubauer-Berrigan MK, Stanescu DO, Thomas BA, Trabalka JR, Gilbert ES, Land CE. Interactive Radioepidemiological Program (IREP): a web-based tool for estimating probability of causation-assigned share for radiological cancers. Health Phys 95:119-147; 2008.
17. Land CE. Low-dose extrapolation of radiation health risks: some implications of uncertainty for radiation protection at low doses. Health Phys 97:407-415; 2009.
18. Mabuchi K, Soda M, Ron E, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Preston DL, Thompson DE. Cancer incidence in atomic bomb survivors. Part I: use of the tumor registries in Hiroshima and Nagasaki for incidence studies. Radiat Res 137(Suppl 2):S1-S16; 1994. (Pubitemid 24060245)
19. National Academy of Sciences/National Research Council. Committee on the Biological Effects of Ionizing Radiation. The effects on populations of exposure to low levels of ionizing radiation: BEIR III. Washington, DC: National Academy Press; 1980.
20. National Academy of Sciences/National Research Council. Oversight Committee on Radioepidemiological Tables. Assigned share for radiation as a cause of cancer-review of radioepidemiological tables assigning probabilities of causation (Final Report). Washington, DC: National Academy Press; 1984.
21. National Academy of Sciences/National Research Council. Committee on the Biological Effects of Ionizing Radiation. Health risks from exposure to low levels of ionizing radiation. BEIR VII Phase 2. Washington, DC: The National Academy Press; 2006.
22. National Council on Radiation Protection and Measurements. A guide for uncertainty analysis in dose and risk assessments related to environmental contamination. Bethesda, MD: NCRP; NCRP Commentary No. 14, 1996.
23. National Council on Radiation Protection and Measurements. Uncertainties in fatal cancer risk estimates used in radiation protection. Bethesda, MD: NCRP; NCRP Report No. 126, 1997.
24. National Institutes of Health. Report of the National Institutes of Health Ad Hoc Working Group to develop radioepide-miological tables. Bethesda, MD: NIH, 1985.
25. National Institutes of Health. Report of the NCI-CDC Working Group to revise the 1985 NIH Radioepidemiological Tables. Bethesda, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute; NIH Publication No. 03-5387; 2003.
26. Otake M, Neriishi K, Schull WJ. Cataract in atomic bomb survivors based on a threshold model and the occurrence of severe epilation. Radiat Res 146:339-348; 1996. (Pubitemid 26320100)
27. Otake M, Schull WJ. Radiation-related brain damage and growth retardation among the prenatally exposed atomic bomb survivors. Int J Radiat Biol 74:159-171; 1998. (Pubitemid 28372544)
28. Oughterson AW, Barnett HL, LeRoy GV, Rosenbaum JD, Liebow AA, Schneider BA, Hammond EC. Medical effects of atomic bombs: The Report of the Joint Commission for the Investigation of the Effects of the Atomic Bomb in Japan, Vol. VI. Oak Ridge, TN: U.S AEC, Technical Information Service; 1951.
29. Pierce DA, Stram DO, Vaeth M. Allowing for random errors in radiation dose estimates for the atomic bomb survivor data. Radiat Res 123:275-284; 1990. (Pubitemid 20327898)
30. Pierce DA, Preston DL. Radiation-related cancer risks at low doses among atomic bomb survivors. Radiat Res 154:178-186; 2000. (Pubitemid 30612918)
31. Pierce DA, Vaeth M, Cologne JB. Allowance for random dose estimation errors in atomic bomb survivor studies: a revision. Radiat Res 170:118-126; 2008. (Pubitemid 351931193)
32. Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Matsui T. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987. Ra-diat Res 137(Suppl 2):S68-97; 1994. (Pubitemid 24060247)
33. [Erratum in Radiat Res 139:129; 1994.]
34. Preston DL, Mattsson A, Holmberg E, Shore R, Hildreth NG, Boice JD Jr. Radiation effects on breast cancer risk: a pooled analysis of eight cohorts. Radiat Res 158:220-235; 2002. (Pubitemid 34851818)
35. Preston DL, Ron E, Tokuoka S, Funamoto S, Nishi N, Soda M, Mabuchi K. Solid cancer incidence in atomic bomb survivors: 1958-1998. Radiat Res 168:1-64; 2007.
36. Ron E, Preston DL, Mabuchi K, Thompson DE, Soda M. Cancer incidence in atomic bomb survivors. Part IV: Comparison of cancer incidence and mortality. Radiat Res 137(Suppl 2):S98-112; 1994.
37. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD. Jr Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277; 1995.
38. Ron E, Preston DL, Kishikawa M, Kobuke T, Iseki M, Tokuoka S, Tokunaga M, Mabuchi K. Skin tumor risk among atomic-bomb survivors in Japan. Cancer Causes Control 9:393-401; 1998. (Pubitemid 28466691)
39. Schull WJ. Cancer risks among atomic bomb survivors. In: Young JR, Yalow RS, eds. Radiation and public perception: benefits and risks. Washington, DC: American Chemical Society; 1995: 147-159.
40. Tanaka K, Kiyohara Y, Kubo M, Matsumoto T, Tanizaki Y, Okubo K, Ninomiya T, Oishi Y, Shikata K, Iida M. Secular trends in the incidence, mortality, and survival rate of gastric cancer in a general Japanese population: the Hi-sayama study. Cancer Causes Control 16:573-578; 2005. (Pubitemid 40933627)
41. Thompson DE, Mabuchi K, Ron E, Soda M, Tokunaga M, Ochikubo S, Sugimoto S, Ikeda T, Terasaki M, Izumi S, Preston DL. Cancer incidence in atomic bomb survivors. Part II: Solid tumors, 1958-1987. Radiat Res 137:S17-S67; 1994. (Pubitemid 24060246)
42. Wakeford R, Antell BA, Leigh WJ. A review of probability of causation and its use in a compensation scheme for nuclear industry workers in the United Kingdom. Health Phys 74:1-9; 1998. (Pubitemid 28035826)
43. Warren-Hicks WJ, Moore DRG. Uncertainty analysis in ecological risk assessment. Pensacola, FL: SETAC Press; 1998.